Celldex Therapeutics Q1 EPS $(0.56) Beats $(0.69) Estimate, Sales $156.00K Miss $920.00K Estimate
Celldex Therapeutics Q1 EPS $(0.56) Beats $(0.69) Estimate, Sales $156.00K Miss $920.00K Estimate
Celldex Therapeutics第一季度每股收益美元（0.56美元）超過預期（0.69美元），銷售額爲15.6萬美元，低於預期的92.00萬美元
Celldex Therapeutics (NASDAQ:CLDX) reported quarterly losses of $(0.56) per share which beat the analyst consensus estimate of $(0.69) by 18.84 percent. This is a 9.68 percent increase over losses of $(0.62) per share from the same period last year. The company reported quarterly sales of $156.00 thousand which missed the analyst consensus estimate of $920.00 thousand by 83.04 percent. This is a 83.87 percent decrease over sales of $967.00 thousand the same period last year.
Celldex Therapeutics（納斯達克股票代碼：CLDX）公佈的季度虧損爲每股0.56美元（0.56美元），比分析師共識估計的美元（0.69美元）高出18.84％。這比去年同期每股虧損0.62美元（0.62美元）增長了9.68％。該公司公佈的季度銷售額爲15.6萬美元，比分析師普遍預期的92萬美元低83.04％。這比去年同期的96.7萬美元銷售額下降了83.87％。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。